Mutations in MBOAT7 , Encoding Lysophosphatidylinositol Acyltransferase I, Lead to Intellectual Disability Accompanied by Epilepsy and Autistic Features
Author(s) -
Anide Johansen,
Rasim Özgür Rosti,
Damir Musaev,
Evan Sticca,
Ricardo Harripaul,
Maha S. Zaki,
Ahmet Okay Çağlayan,
Matloob Azam,
Tipu Sultan,
Tawfiq Froukh,
André Reis,
Bernt Popp,
Iltaf Ahmed,
Peter John,
Muhammad Ayub,
Tawfeg BenOmran,
John B. Vincent,
Joseph G. Gleeson,
Rami Abou Jamra
Publication year - 2016
Publication title -
the american journal of human genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.661
H-Index - 302
eISSN - 1537-6605
pISSN - 0002-9297
DOI - 10.1016/j.ajhg.2016.07.019
Subject(s) - epilepsy , intellectual disability , autism , acyltransferase , lead (geology) , genetics , psychiatry , psychology , biology , gene , paleontology
The risk of epilepsy among individuals with intellectual disability (ID) is approximately ten times that of the general population. From a cohort of >5,000 families affected by neurodevelopmental disorders, we identified six consanguineous families harboring homozygous inactivating variants in MBOAT7, encoding lysophosphatidylinositol acyltransferase (LPIAT1). Subjects presented with ID frequently accompanied by epilepsy and autistic features. LPIAT1 is a membrane-bound phospholipid-remodeling enzyme that transfers arachidonic acid (AA) to lysophosphatidylinositol to produce AA-containing phosphatidylinositol. This study suggests a role for AA-containing phosphatidylinositols in the development of ID accompanied by epilepsy and autistic features.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom